Key result
Persistent coronary endothelial dysfunction is linked to a ~6-fold increase in plaque progression after STEMI.
Why the study?
Few human studies have examined the relationship between coronary endothelial vasomotor dysfunction and atheroma plaque progression in the same coronary artery after STEMI.
Cohort (n=50)
No
Answers are grounded in this paper and cite their sources.
Persistent endothelial dysfunction may flag STEMI survivors for plaque progression risk; extends prior vasomotor-event links but leaves open therapeutic implications.
AIM: Although coronary endothelial vasomotor dysfunction predicts future coronary events, there are few human studies showing the relationship between endothelial vasomotor dysfunction and atheroma plaque progression in the same coronary artery. This study examined whether endothelial vasomotor dysfunction is related to atheroma plaque progression in the infarct-related coronary artery of ST-segment elevation myocardial infarction (STEMI) survivors using serial assessment of coronary plaque size with intravascular ultrasound (IVUS) and coronary vasomotor responses to acetylcholine (ACh). METHODS: test) after AMI under optimal anti-atherosclerotic therapies. RESULTS: tests. PAV and TAV progression had no significant association with traditional risk factors, PCI-related variables, medications, and the coronary vasomotor responses to sodium nitroprusside, an endothelium-independent vasodilator. CONCLUSIONS: Persistent impairment of endothelial vasomotor function in the conduit arterial segment and the resistance arteriole was related to atheromatous plaque progression in the infarct-related coronary arteries of STEMI survivors.
No takes yet. Share an insight, caveat, or question.
Horikoshi et al. (2019) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=50). Persistent impairment of coronary endothelial vasomotor response to acetylcholine vs. No persistent impairment of coronary endothelial vasomotor response was evaluated on Progression of percent atheroma volume (PAV) over 6 months (OR 6.15, 95% CI 1.35-28.13, p=0.02). Persistent impairment of epicardial coronary diameter response to acetylcholine was significantly associated with atheroma plaque progression in the infarct-related coronary artery of STEMI survivors (OR 6.15).
Synapse has enriched 10 related papers. Consider them for comparative context: